PHASE-II TRIAL OF DOXORUBICIN IN BIDIMENSIONALLY MEASURABLE PROSTATIC ADENOCARCINOMA

被引：44
作者：
SCHER, H
YAGODA, A
WATSON, RC
SERBER, M
WHITMORE, W
机构：
[1] MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,DEPT DIAGNOST RADIOL,NEW YORK,NY 10021
[3] MEM SLOAN KETTERING CANC CTR,DEPT SURG,UROL SERV,NEW YORK,NY 10021
来源：
JOURNAL OF UROLOGY | 1984年 / 131卷 / 06期
关键词：
D O I：
10.1016/S0022-5347(17)50829-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1099 / 1102
页数：4
相关论文
共 23 条
[1]  
BERRY WR, 1979, CANCER, V44, P763, DOI 10.1002/1097-0142(197908)44:2<763::AID-CNCR2820440251>3.0.CO
[2]  
2-5
[3]   SYSTEMIC TREATMENT OF ADVANCED PROSTATIC-CANCER - DEVELOPMENT OF A NEW SYSTEM FOR DEFINING RESPONSE [J].
CITRIN, DL ;
COHEN, AI ;
HARBERG, J ;
SCHLISE, S ;
HOUGEN, C ;
BENSON, R .
JOURNAL OF UROLOGY, 1981, 125 (02) :224-227
[4]  
DEWYS W, 1978, P AM ASS CANCER RES, V19, P338
[5]   A COMPARATIVE CLINICAL-TRIAL OF ADRIAMYCIN AND 5-FLUOROURACIL IN ADVANCED PROSTATIC-CANCER - PROGNOSTIC FACTORS AND RESPONSE [J].
DEWYS, WD ;
BEGG, CB ;
BRODOVSKY, H ;
CREECH, R ;
KHANDEKAR, J .
PROSTATE, 1983, 4 (01) :1-11
[6]  
EAGAN RT, 1976, CANCER TREAT REP, V60, P115
[7]  
IHDE DC, 1980, CANCER, V45, P1300, DOI 10.1002/1097-0142(19800315)45:6<1300::AID-CNCR2820450606>3.0.CO
[8]  
2-0
[9]  
OBRYAN RM, 1973, CANCER-AM CANCER SOC, V32, P1, DOI 10.1002/1097-0142(197307)32:1<1::AID-CNCR2820320101>3.0.CO
[10]  
2-X
123